Rohto Pharmaceutical Co.,Ltd. (TYO: 4527)

Rohto Pharmaceutical Co.,Ltd. Statistics

Total Valuation

Rohto Pharmaceutical Co.,Ltd. has a market cap or net worth of JPY 620.31 billion. The enterprise value is 611.65 billion.

Market Cap	620.31B
Enterprise Value	611.65B

Important Dates

The next estimated earnings date is Wednesday, February 12, 2025.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Rohto Pharmaceutical Co.,Ltd. has 228.14 million shares outstanding. The number of shares has increased by 0.00% in one year.

Current Share Class	n/a
Shares Outstanding	228.14M
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	3.42%
Owned by Institutions (%)	40.51%
Float	204.93M

Valuation Ratios

The trailing PE ratio is 22.82 and the forward PE ratio is 18.34.

PE Ratio	22.82
Forward PE	18.34
PS Ratio	2.20
PB Ratio	2.45
P/TBV Ratio	3.18
P/FCF Ratio	20.44
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.46, with an EV/FCF ratio of 20.16.

EV / Earnings	22.44
EV / Sales	2.17
EV / EBITDA	13.46
EV / EBIT	16.78
EV / FCF	20.16

Financial Position

The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.17.

Current Ratio	1.84
Quick Ratio	1.20
Debt / Equity	0.17
Debt / EBITDA	0.97
Debt / FCF	1.47
Interest Coverage	170.99

Financial Efficiency

Return on equity (ROE) is 10.88% and return on invested capital (ROIC) is 8.24%.

Return on Equity (ROE)	10.88%
Return on Assets (ROA)	6.18%
Return on Capital (ROIC)	8.24%
Revenue Per Employee	38.86M
Profits Per Employee	3.76M
Employee Count	7,259
Asset Turnover	0.76
Inventory Turnover	2.18

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.92% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-3.92%
50-Day Moving Average	3,084.50
200-Day Moving Average	3,168.41
Relative Strength Index (RSI)	34.78
Average Volume (20 Days)	855,485

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Rohto Pharmaceutical Co.,Ltd. had revenue of JPY 282.05 billion and earned 27.26 billion in profits. Earnings per share was 119.15.

Revenue	282.05B
Gross Profit	161.83B
Operating Income	36.76B
Pretax Income	37.55B
Net Income	27.26B
EBITDA	45.77B
EBIT	36.76B
Earnings Per Share (EPS)	119.15

Balance Sheet

The company has 64.50 billion in cash and 44.54 billion in debt, giving a net cash position of 19.97 billion or 87.52 per share.

Cash & Cash Equivalents	64.50B
Total Debt	44.54B
Net Cash	19.97B
Net Cash Per Share	87.52
Equity (Book Value)	264.35B
Book Value Per Share	1,109.15
Working Capital	93.75B

Cash Flow

In the last 12 months, operating cash flow was 39.44 billion and capital expenditures -9.10 billion, giving a free cash flow of 30.34 billion.

Operating Cash Flow	39.44B
Capital Expenditures	-9.10B
Free Cash Flow	30.34B
FCF Per Share	133.00

Margins

Gross margin is 57.38%, with operating and profit margins of 13.03% and 9.67%.

Gross Margin	57.38%
Operating Margin	13.03%
Pretax Margin	13.31%
Profit Margin	9.67%
EBITDA Margin	16.23%
EBIT Margin	13.03%
FCF Margin	10.76%

Dividends & Yields

This stock pays an annual dividend of 34.00, which amounts to a dividend yield of 1.25%.

Dividend Per Share	34.00
Dividend Yield	1.25%
Dividend Growth (YoY)	29.17%
Years of Dividend Growth	3
Payout Ratio	22.59%
Buyback Yield	-0.00%
Shareholder Yield	1.25%
Earnings Yield	4.38%
FCF Yield	4.89%

Stock Splits

The last stock split was on December 29, 2022. It was a forward split with a ratio of 2.

Last Split Date	Dec 29, 2022
Split Type	Forward
Split Ratio	2

Scores

Rohto Pharmaceutical Co.,Ltd. has an Altman Z-Score of 5.02.

Altman Z-Score	5.02
Piotroski F-Score	n/a